Biosensors Market Forecast 2025-2033: Total Revenues to Exceed $75.84 Billion by 2033 | Astute Analytica [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
Rising chronic disease prevalence, point-of-care diagnostics, wearable and embedded devices, and IoT integration are accelerating market growth, while technological advances in electrochemical, optical, and graphene-based sensors enhance precision, efficiency, and accessibility. Chicago, Jan. 22, 2026 (GLOBE NEWSWIRE) -- The global biosensors market was valued at 32.15 billion in 2024 and is expected to reach US$ 75.84 billion by 2033, growing at a CAGR of 10.40% from 2025 to 2033. Propelled by surging chronic diseases, the global biosensors market is redefining healthcare diagnostics. More than 422 million diabetic adults (WHO) now depend on continuous glucose monitors (CGMs), with Abbott's FreeStyle Libre dominating the U.S. market, serving 4 million users. This innovation isn't isolated: cardiovascular diseases, responsible for 17.9 million annual deaths (WHO), are being tackled via point-of-care biosensors that reduce cardiac troponin detection from six hours to 10 minutes, ac
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- 3 Analyst-Approved Stocks With Fat Yields That Could Rally 27% or More [Yahoo! Finance]Yahoo! Finance
- Abbott Laboratories (ABT) had its price target lowered by Citigroup Inc. from $140.00 to $136.00. They now have a "buy" rating on the stock.MarketBeat
- Why Abbott (ABT) is a Top Value Stock for the Long-Term [Yahoo! Finance]Yahoo! Finance
- Abbott and Real Madrid launch nationwide effort to build the next 'Abbott Dream Team' [Yahoo! Finance]Yahoo! Finance
- Abbott and Real Madrid launch nationwide effort to build the next 'Abbott Dream Team'PR Newswire
ABT
Earnings
- 1/22/26 - In-Line
ABT
Sec Filings
- 3/9/26 - Form 8-K
- 3/3/26 - Form 4
- 3/3/26 - Form 4
- ABT's page on the SEC website